Ozempic and Wegovy have become two of the fastest-selling drugs ever, irrevocably changing the obesity treatment landscape - but there have been a couple of catches. Novo Nordisk, the Danish company behind Wegovy and Ozempic, as well as Indiana-based Eli Lilly and New York-based Pfizer, are vying to become the first company to introduce a highly effective, safe, and extremely …
